Mindpeak and DigitCells Partner to Enhance AI Pathology Workflows
DigitCells and Mindpeak have announced a strategic partnership to enhance digital pathology workflows by integrating AI algorithms, as stated in a press release. This collaboration aims to improve diagnostic accuracy and efficiency in pathology laboratories across the nation.
The partnership will see Mindpeak's AI algorithms integrated into DigitCells' advanced digital pathology platform, particularly focusing on breast cancer applications initially. The integration is expected to streamline workflows, enhance diagnostic precision, and optimize laboratory processes. A nationwide rollout of this integrated solution is planned for 2025, leveraging the infrastructure of DigitCells' parent company, GoPath Diagnostics.
Additionally, Mindpeak and GoPath Diagnostics will collaborate on developing AI tools for prostate cancer diagnostics. This effort will focus on automated tumor segmentation and scoring, aiming to improve diagnostic outcomes. The partnership also plans to expand the integration to include applications in gastrointestinal and dermatopathology by the end of the year.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
MGI Tech Launches VisiOmics in Europe
HiRO and Differentia Biotech Sign MOU for AI Clinical Trial Simulation
MediSights Reports Study Using AI Agents for Myeloma Market Research
UT Medical and TransformativeMed Build Agentic AI Discharge Planning Tool
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Daily AI Brief: the AI news that matters, in your inbox.